Celldex Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Amgen USD 33.53B 140M 2024-12
Bristol-Myers Squibb USD 292M 0 2025-03
Celldex Therapeutics USD 66K 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Pfizer USD 480M 0 2024-12
Roche Holding CHF 107M 0 2024-06



Celldex Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.